Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates.
Amarin stock last closed at $15.69, up 0.9% from the previous day, and has increased 32.52% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.06 percentage points. Amarin stock is currently +121.61% from its 52-week low of $7.08, and -24.93% from its 52-week high of $20.90.
At the moment, there are 415.85M AMRN shares outstanding. The market capitalization of AMRN is $326.24M. In the past 24 hours, 35,700 AMRN shares were traded.
You need an online brokerage account to access the NASDAQ market and buy AMRN stock.
We believe that eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, the next step is to fill out some personal info so you are able to buy AMRN today.
Now that you've finished signing up on one of the most highly reviewed stock trading apps, you need to deposit funds:
Watch the video below for more details transferring funds into your brokerage account.
Once you have selected the best place to buy Amarin stock, it's important to evaluate their stock before you buy, so you actually wrap your head around the risk and opportunity.
WallStreetZen was created to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on AMRN's stock page.
You can use many financial metrics, analyses, models, and charts to gauge AMRN's fair value.
Using relative valuations ratios:
You can access more valuation analysis on AMRN's stock here.
You can dive deeper into what analysts are forecasting on the Amarin stock forecast page.
Last year, AMRN revenue was $226.73M. During the last five year, AMRN's revenue has increased by -17.41% per year. This was slower than the Drug Manufacturers - General industry average of 10.71%.
Find out more about AMRN's earnings and revenue performance here.
Over the last year, executives and large shareholders at AMRN have sold more shares than they have bought.
Peter L. Fishman, SVP CFO of AMRN, was the latest AMRN insider to sell. They sold $18,929.76 worth of AMRN shares on Jan 2, 2026.
Get more info about who owns AMRN shares here.
No, Amarin doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two main order types:
Press the Open Trade button and eToro will execute your order.
If you require more assistance investing in stocks on eToro, click the how to video below:
Now that you own some AMRN stock, you'll want to keep up with your new company.
Make a watchlist to track your AMRN stock.
To reiterate, here are the 6 steps to buy stock in Amarin:
If you require a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Amarin, create a watchlist today.